The Chinese have done well out of the deal. I wonder if that forced Merck's hand. Will Bristol MS have a go. I would have thought that they need CAVATAK even more than Merck. They need to move quick! cheers
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025